Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Trichophyton bullosum has been found causing severe skin infections in donkeys in North Africa for the first time since 1933.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

People with Alopecia Areata have a higher risk of heart-related health issues.

PCOS is a common disorder in women causing symptoms like irregular periods and weight gain, with management possible through lifestyle changes and medication.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Obesity and lifestyle strongly affect heart aging.

PCOS has no cure, but treatments can manage symptoms and improve health.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

DHT may increase the risk of heart disease and death in elderly men.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Graying hair happens due to aging and might be delayed by new treatments.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Cholesterol transport in hair follicles decreases from growth to regression phase.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Diagonal earlobe crease and lipoprotein(a) together help diagnose coronary heart disease.

There is no significant link between metabolic syndrome and alopecia areata.